{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T16:27:44Z","timestamp":1789921664198,"version":"4.0.1"},"reference-count":44,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Since the introduction of the hepatitis B virus (HBV) vaccination program in Oman in 1990, the HBV prevalence has markedly decreased. However, hepatitis D virus (HDV) infection, which is associated with progressive liver disease in patients with chronic HBV, remains understudied in the Omani population. This study aimed to estimate HDV\u2019s seroprevalence, characterize its virological and clinical features, and identify factors associated with anti-HDV positivity among adult Omani patients with chronic HBV infection. Methods: We conducted a multicenter cross-sectional study in 2024 at two referral hospitals and two polyclinics in Oman. Adult Omani patients with chronic HBV (HBsAg-positive for &gt;6 months) were enrolled. Demographic, clinical, laboratory, imaging, and elastography data were collected. The total anti-HDV antibodies were tested using an ELISA; HDV RNA was tested for anti-HDV-positive or equivocal results. Liver Fibrosis was assessed non-invasively through liver stiffness measurement (LSM) using vibration-controlled transient elastography (VCTE); FibroScan\u00ae and clinical evaluation. Ridge (penalized) logistic regression identified predictors independently associated with anti-HDV positivity. Results: Among 639 patients (59.3% male; mean age of 46.6 \u00b1 8.8 years), 36 patients were anti-HDV-positive, resulting in an HDV seroprevalence of 5.6% (95% CI: Exact 3.98\u20137.71; Wilson 4.10\u20137.70). Only one anti-HDV-positive patient had detectable HDV RNA, which became undetectable on follow-up without HDV treatment. The anti-HDV-positive patients were more frequently female and had a higher frequency of prior blood transfusions. In a penalized multivariable analysis, blood transfusions were independently associated with anti-HDV positivity (OR of 19.94), whereas male sex was associated with lower odds of being anti-HDV-positive (OR of 0.15). All the anti-HDV-positive patients had mild fibrosis (F0\u2013F1). Conclusions: Our study demonstrated an anti-HDV prevalence of 5.63% among adult Omani patients with chronic HBV infection, while active viremia appeared to be rare. Blood transfusions were the main identified risk factor. Given the very low HDV viremia, targeted screening of higher-risk groups may be efficient.<\/jats:p>","DOI":"10.3390\/jcm14197089","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:22:08Z","timestamp":1759911728000},"page":"7089","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Seroprevalence, Risk Factors, and Clinical Profile of Hepatitis D in Omani Patients with Chronic Hepatitis B: A Multicenter Cross-Sectional Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2892-266X","authenticated-orcid":false,"given":"Khalid M.","family":"AlNaamani","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Al-Tamtami","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, Division of Medical Microbiology, The Medical City for Military and Security Services, Muscat 111, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3396-6894","authenticated-orcid":false,"given":"Mohamed","family":"El-Kassas","sequence":"additional","affiliation":[{"name":"Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo 11795, Egypt"},{"name":"Applied Science Research Center, Applied Science Private University, Amman 11931, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9707-1141","authenticated-orcid":false,"given":"Heba","family":"Omar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman"},{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University, Cairo 11562, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"AlKalbani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bola. R.","family":"Kamath","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6168-5601","authenticated-orcid":false,"given":"Halima","family":"Alshuaili","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4300-5920","authenticated-orcid":false,"given":"Amal","family":"Anwar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alya","family":"AlKalbani","sequence":"additional","affiliation":[{"name":"Department of Nursing, The Medical City for Military and Security Services, Muscat 111, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajer","family":"AlShukaili","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, Division of Medical Microbiology, The Medical City for Military and Security Services, Muscat 111, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"AlSawafi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneera","family":"AlShukaili","sequence":"additional","affiliation":[{"name":"Department of Nursing, The Medical City for Military and Security Services, Muscat 111, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siham","family":"AlSinani","sequence":"additional","affiliation":[{"name":"Department of Child Health, Sultan Qaboos University Hospital, University Medical City, Muscat 123, Oman"},{"name":"Department of Child Health, Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat 123, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jare.2019.03.009","article-title":"A review on hepatitis D: From virology to new therapies","volume":"17","author":"Mentha","year":"2019","journal-title":"J. Adv. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/gutjnl-2020-323888","article-title":"Hepatitis D virus in 2021: Virology, immunology and new treatment approaches for a difficult-to-treat disease","volume":"70","author":"Urban","year":"2021","journal-title":"Gut"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1001\/jama.2023.23242","article-title":"Hepatitis D: A Review","volume":"330","author":"Negro","year":"2023","journal-title":"Jama"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2023.05.001","article-title":"EASL Clinical Practice Guidelines on hepatitis delta virus","volume":"79","author":"Brunetto","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e26571","DOI":"10.1097\/MD.0000000000026571","article-title":"Poor clinical and virological outcome of nucleos (t) ide analogue monotherapy in HBV\/HDV co-infected patients","volume":"100","author":"Scheller","year":"2021","journal-title":"Medicine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis","volume":"73","author":"Stockdale","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1007\/s10620-023-07960-y","article-title":"Diagnosis and management of hepatitis delta virus infection","volume":"68","author":"Pan","year":"2023","journal-title":"Dig. Dis. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jhep.2023.10.043","article-title":"Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories","volume":"80","author":"Child","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1053\/jhep.2000.17711","article-title":"Chronic hepatitis D: A vanishing Disease? An Italian multicenter study","volume":"32","author":"Gaeta","year":"2000","journal-title":"Hepatology"},{"key":"ref_10","first-page":"380","article-title":"Characteristics of hepatitis B infection in a sample of Omani patients","volume":"13","year":"2013","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4269\/ajtmh.13-0333","article-title":"Progress toward elimination of hepatitis B virus transmission in Oman: Impact of hepatitis B vaccination","volume":"89","author":"Bawikar","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.5001\/omj.2022.54","article-title":"Hepatitis B related liver cirrhosis in Oman","volume":"37","author":"Omer","year":"2022","journal-title":"Oman Med. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"83","author":"Cornberg","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.meegid.2018.06.013","article-title":"Molecular epidemiology of hepatitis delta and hepatitis B viruses circulating in two major provinces (East and North-West) of Pakistan","volume":"64","author":"Aftab","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"ref_15","first-page":"220","article-title":"Epidemiology of Hepatitis D Virus and Associated Factors in Patients Referred to Level Three Hepatitis Clinic, Fars Province, Southern Iran","volume":"50","author":"Safarpour","year":"2025","journal-title":"Iran. J. Med. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.5001\/omj.2024.69","article-title":"Medical Tourism and Neurological Diseases: Omani Patients\u2019 Experience Seeking Treatment Abroad","volume":"39","year":"2024","journal-title":"Oman Med. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5144\/0256-4947.1994.312","article-title":"Hepatitis B, delta and human immunodeficiency virus infections among Omani patients with renal diseases: A seroprevalence study","volume":"14","author":"Aghanashinikar","year":"1994","journal-title":"Ann. Saudi Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Coller, K.E., Butler, E.K., Luk, K.-C., Rodgers, M.A., Cassidy, M., Gersch, J., McNamara, A.L., Kuhns, M.C., Dawson, G.J., and Kaptue, L. (2018). Development and performance of prototype serologic and molecular tests for hepatitis delta infection. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-20455-5"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.transci.2017.04.003","article-title":"Status of blood transfusion in World Health Organization-Eastern Mediterranean Region (WHO-EMR): Successes and challenges","volume":"56","author":"Darbandi","year":"2017","journal-title":"Transfus. Apher. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/liv.15338","article-title":"Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East: A scoping review","volume":"43","author":"Lazarus","year":"2023","journal-title":"Liver Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/infdis\/jiz633","article-title":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection","volume":"221","author":"Miao","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/gutjnl-2018-316601","article-title":"Prevalence and burden of hepatitis D virus infection in the global population: A systematic review and meta-analysis","volume":"68","author":"Chen","year":"2019","journal-title":"Gut"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/liv.13604","article-title":"Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)","volume":"38","author":"Wranke","year":"2018","journal-title":"Liver Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.29574","article-title":"Genetic diversity and worldwide distribution of the deltavirus genus: A study of 2,152 clinical strains","volume":"66","author":"Brichler","year":"2017","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1053\/j.gastro.2006.01.035","article-title":"Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients","volume":"130","author":"Su","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"105850","DOI":"10.1016\/j.jcv.2025.105850","article-title":"Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study","volume":"180","author":"Salpini","year":"2025","journal-title":"J. Clin. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Adepoju, V.A., Udah, D.C., and Adnani, Q.E.S. (2024). Prevalence, Risk Factors, and Clinical Profiles of Hepatitis D Virus in Nigeria: A Systematic Review, 2009-2024. Viruses, 16.","DOI":"10.3390\/v16111723"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.15403\/jgld.2014.1121.244.dtv","article-title":"Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors","volume":"24","author":"Gheorghe","year":"2015","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jmii.2021.03.014","article-title":"Investigating the prevalence and clinical effects of hepatitis delta viral infection in Taiwan","volume":"54","author":"Lee","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e012210","DOI":"10.1136\/bmjopen-2016-012210","article-title":"Gender disparities in red blood cell transfusion in elective surgery: A post hoc multicentre cohort study","volume":"6","author":"Gombotz","year":"2016","journal-title":"BMJ Open"},{"key":"ref_31","first-page":"147","article-title":"Gender differences in the utilization of health care services","volume":"49","author":"Bertakis","year":"2000","journal-title":"J. Fam. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"100547","DOI":"10.1016\/j.jhepr.2022.100547","article-title":"Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D","volume":"4","author":"Palom","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajg.2017.11.003","article-title":"Prevalence and risk factors of hepatitis D virus infection in patients with chronic hepatitis B infection attending the three main tertiary hospitals in Libya","volume":"18","author":"Elzouki","year":"2017","journal-title":"Arab. J. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.18295\/squmj.2018.18.01.002","article-title":"Transfusion in Haemoglobinopathies: Review and recommendations for local blood banks and transfusion services in Oman","volume":"18","author":"Daar","year":"2018","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.5001\/omj.2021.99","article-title":"Risk factors for hepatitis B virus transmission in Oman","volume":"36","author":"Priest","year":"2021","journal-title":"Oman Med. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MEG.0000000000000795","article-title":"Prevalence and epidemiology of hepatitis D among patients with chronic hepatitis B virus infection: A report from Northern Spain","volume":"29","author":"Ordieres","year":"2017","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/liv.15519","article-title":"Hepatitis delta infection among persons living with HIV in Europe","volume":"43","author":"Atkinson","year":"2023","journal-title":"Liver Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cld.2023.05.010","article-title":"Triple Threat: HDV, HBV, HIV Coinfection","volume":"27","author":"Yen","year":"2023","journal-title":"Clin. Liver Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jhep.2020.06.038","article-title":"Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta","volume":"73","author":"Roulot","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/apt.15521","article-title":"Long-term clinical outcomes in patients with chronic hepatitis delta: The role of persistent viraemia","volume":"51","author":"Palom","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/hep.31214","article-title":"Long-term study of hepatitis delta virus infection at secondary care centers: The impact of viremia on liver-related outcomes","volume":"72","author":"Kamal","year":"2020","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Bockmann, J.-H., Grube, M., Hamed, V., von Felden, J., Landahl, J., Wehmeyer, M., Giersch, K., Hall, M.T., Murray, J.M., and Dandri, M. (2020). High rates of cirrhosis and severe clinical events in patients with HBV\/HDV co-infection: Longitudinal analysis of a German cohort. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-1168-9"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: A 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol. Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/19\/7089\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:50:22Z","timestamp":1760035822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/19\/7089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":44,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["jcm14197089"],"URL":"https:\/\/doi.org\/10.3390\/jcm14197089","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]}}}